Tibet Kang Zhe Pharmaceutical Technology Co., Ltd Report issue

For profit
Founded: Lhasa China (2015)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2017
NCT03207295
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Tibet Kang Zhe Pharmaceutical Technology Co., Ltd

Active Ingredients

Drugs in Other Trials (1)

nesiritide (natrecor) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1